Renal medicine, Kolling Institute, Royal North Shore Hospital, University of Sydney, Sydney, NSW, Australia.
School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, NSW, Australia.
J Physiol. 2019 Jan;597(2):467-480. doi: 10.1113/JP276957. Epub 2018 Oct 31.
Maternal high-fat diet (MHF) consumption led to metabolic and liver disorders in male offspring, which are associated with reduced sirtuin (SIRT)1 expression and activity in the offspring liver SIRT1 overexpression in MHF offspring reduced their body weight and adiposity and normalized lipid metabolic markers in epididymal and retroperitoneal adipose tissues SIRT1 overexpression in MHF offspring improved glucose tolerance, as well as systemic and hepatic insulin sensitivity SIRT1 overexpression ameliorated MHF-induced lipogenesis, oxidative stress and fibrogenesis in the liver of offspring.
Maternal obesity can increase the risk of metabolic disorders in the offspring. However, the underlying mechanism responsible for this is not clearly understood. Previous evidence implied that sirtuin (SIRT)1, a potent regulator of energy metabolism and stress responses, may play an important role. In the present study, we have shown, in C57BL/6 mice, that maternal high-fat diet (HFD) consumption can induce a pre-diabetic and non-alcoholic fatty liver disease phenotype in the offspring, associated with reduced SIRT1 expression in the hypothalamus, white adipose tissues (WAT) and liver. Importantly, the overexpression of SIRT1 in these offspring significantly attenuated the excessive accumulation of epididymal (Epi) white adipose tissue (WAT) and retroperitoneal (Rp)WAT (P < 0.001), glucose intolerance and insulin resistance (both P < 0.05) at weaning age. These changes were associated with the suppression of peroxisome proliferator-activated receptor gamma (PPAR)γ (P < 0.01), PPARγ-coactivator 1-alpha (P < 0.05) and sterol regulatory element-binding protein-1c in EpiWAT (P < 0.01), whereas there was increased expression of PPARγ in RpWAT (P < 0.05). In the liver, PPARγ mRNA expression, as well as Akt protein expression and activity, were increased (P < 0.05), whereas fatty acid synthase and carbohydrate response element binding protein were downregulated (P < 0.05), supporting increased insulin sensitivity and reduced lipogenesis in the liver. In addition, hepatic expression of endogenous anti-oxidants, including glutathione peroxidase 1 and catalase, was increased (P < 0.01 and P < 0.05 respectively), whereas collagen and fibronectin deposition was suppressed (P < 0.01). Collectively, the present study provides direct evidence of the mechanistic significance of SIRT1 in maternal HFD-induced metabolic dysfunction in offspring and suggests that SIRT1 is a promising target for fetal reprogramming.
母体高脂肪饮食(MHF)导致雄性后代出现代谢和肝脏紊乱,这与后代肝脏中沉默调节蛋白(SIRT)1 表达和活性降低有关。MHF 后代中 SIRT1 的过表达降低了其体重和脂肪含量,并使附睾和腹膜后脂肪组织中的脂质代谢标志物正常化。MHF 后代中 SIRT1 的过表达改善了葡萄糖耐量以及全身和肝脏胰岛素敏感性。SIRT1 的过表达改善了 MHF 诱导的后代肝脏中的脂肪生成、氧化应激和纤维化。
母体肥胖会增加后代发生代谢紊乱的风险,但导致这种情况的潜在机制尚不清楚。先前的证据表明,沉默调节蛋白(SIRT)1 作为能量代谢和应激反应的有力调节剂,可能发挥重要作用。在本研究中,我们在 C57BL/6 小鼠中表明,母体高脂肪饮食(HFD)消耗可诱导后代出现糖尿病前期和非酒精性脂肪肝疾病表型,与下丘脑、白色脂肪组织(WAT)和肝脏中 SIRT1 表达降低有关。重要的是,这些后代中 SIRT1 的过表达在断奶时显著减轻了附睾(Epi)白色脂肪组织(WAT)和腹膜后(Rp)WAT 的过度积累(P < 0.001)、葡萄糖耐量受损和胰岛素抵抗(均 P < 0.05)。这些变化与过氧化物酶体增殖物激活受体γ(PPAR)γ(P < 0.01)、PPARγ 共激活因子 1-α(P < 0.05)和固醇调节元件结合蛋白-1c 在 EpiWAT 中的抑制有关(P < 0.01),而 RpWAT 中的 PPARγ 表达增加(P < 0.05)。在肝脏中,PPARγ mRNA 表达以及 Akt 蛋白表达和活性增加(P < 0.05),而脂肪酸合成酶和碳水化合物反应元件结合蛋白下调(P < 0.05),支持肝脏中胰岛素敏感性增加和脂肪生成减少。此外,肝脏中内源性抗氧化剂,包括谷胱甘肽过氧化物酶 1 和过氧化氢酶的表达增加(分别为 P < 0.01 和 P < 0.05),而胶原和纤维连接蛋白沉积减少(P < 0.01)。总之,本研究提供了母体 HFD 诱导的后代代谢功能障碍中 SIRT1 机制意义的直接证据,并表明 SIRT1 是胎儿重编程的有希望的靶点。